Search
-
Ipsos Core Political : Presidential Approval Tracker (05/04/2022)
This week's Ipsos Core Political finds President Biden with a 44% approval rating
-
Americans (24%) More Likely Than Canadians (17%) to Invest in Bitcoin as a Short-Term Speculative Investment
Both countries fall behind the average of the 20 countries/economies surveyed.
-
Few Americans understand the Federal Reserve’s role outside curbing inflation
New Axios/Ipsos poll also finds fewer believe the Fed is doing a good job compared to last spring
-
Most Americans oppose penalizing businesses over their stance on social issues
A new Reuters/Ipsos poll finds most Americans are likely to support a political candidate who believes businesses and corporations have the same right to free speech as regular Americans
-
Parents report improvements in their child’s educational attainment compared to last year
New NPR/Ipsos poll also finds that despite debates over parents’ rights in education, most parents believe their child’s school keeps them well-informed on the curriculum
-
Americans’ mood connected to perceived quality of skin
New Ipsos poll finds skin care products are an essential purchase for many
-
Ipsos Core Political : Presidential Approval Tracker (04/27/2022)
This week’s Ipsos’ Core Political finds President Biden with a 42% approval rating as the economy continues to top the list of problems in the country
-
A plurality believe Musk’s purchase of Twitter will lead to greater free speech on the platform
Our latest Ipsos poll finds most heavy Twitter users believe Musk's purchase of Twitter will cause the platform to allow greater free speech
-
Americans are worried about Russia influencing the 2022 midterms
The latest wave of our Reuters/Ipsos poll tracking the Russia/Ukraine crisis, finds American’s impressions of how President Joe Biden is handling the conflict largely unchanged from a month ago.
-
TECHQUITY: Supporting an equitable future for health in the digital era
Revisit our on demand webinar to hear Ipsos healthcare experts and guest panelists discuss industry research and the importance of health technology equity.